Table 2 Baseline descriptive (n = 166), presented by treatment strategy
Variable | HSEP n = 56 | SEP n = 54 | WA n = 56 |
|---|---|---|---|
Gender, female, n (%) | 21 (37.5) | 23 (42.6) | 24 (42.9) |
Age, years, mean (SD) | 71.8 (6.5) | 72.2 (7.5) | 72.5 (8.2) |
Ankle-brachial index, mean (SD) | 0.66 (0.27) | 0.64 (0.18) | 0.67 (0.21) |
Affected leg, n (%) | |||
Right | 15 (26.8) | 13 (24.1) | 16 (28.6) |
Left | 14 (25.0) | 12 (22.2) | 17 (30.4) |
Both | 27 (48.2) | 29 (53.7) | 23 (41.1) |
Rutherford classification, n (%) | |||
Mild claudication | 8 (14.3) | 11 (20.4) | 11 (19.6) |
Moderate claudication | 34 (60.7) | 33 (61.1) | 35 (62.5) |
Severe claudication | 14 (25.0) | 10 (18.5) | 10 (17.9) |
Smoking, n (%) | |||
Yes | 15 (26.8) | 16 (29.6) | 16 (28.6) |
Earlier | 37 (66.1) | 33 (61.1) | 34 (60.7) |
Never | 4 (7.1) | 5 (9.3) | 6 (10.7) |
Physical activitya, yes, n (%) | 16 (28.6) | 16 (29.6) | 21 (37.5) |
Co-morbidity, n (%) | |||
Heart diseaseb | 18 (32.1) | 18 (33.3) | 17 (30.4) |
Chronic obstructive pulmonary disease | 8 (14.3) | 8 (14.8) | 7 (12.5) |
Diabetes mellitus | 19 (33.9) | 14 (25.9) | 16 (28.6) |